Calouste Gulbenkian Foundation
Overview
Calouste Gulbenkian Foundation is a Portuguese private institution of public utility whose statutory purposes are in the fields of arts, charity, science, and education. Established in 1956, the foundation manages a large endowment to fund its activities, which include direct grants, scholarships, and operating a museum, orchestra, and scientific research institute. It also allocates a portion of its assets to private equity and makes impact investments.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BioSolvit | Nov 2019 | Grant | Co-investor |
| Proteon Pharmaceuticals | Nov 2022 | Grant | Co-investor |
| Algaesys | - | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Calouste Gulbenkian Foundation based?
Calouste Gulbenkian Foundation is headquartered in Lisbon, Portugal.
When was Calouste Gulbenkian Foundation founded?
Calouste Gulbenkian Foundation was founded in 1956.
How many portfolio companies does Calouste Gulbenkian Foundation have?
Calouste Gulbenkian Foundation has 5 portfolio companies in Caplight's dataset.
What are some companies in Calouste Gulbenkian Foundation's portfolio?
Portfolio companies visible on Caplight include BioSolvit, Proteon Pharmaceuticals, Algaesys.
What was Calouste Gulbenkian Foundation's most recent investment shown here?
Calouste Gulbenkian Foundation's most recent investment in this portfolio sample was in Proteon Pharmaceuticals in 2022.
What sectors does Calouste Gulbenkian Foundation focus on?
Calouste Gulbenkian Foundation focuses on Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Energy & Sustainability, Media, Entertainment & Gaming, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech.
What company stages does Calouste Gulbenkian Foundation focus on?
Calouste Gulbenkian Foundation typically invests at the Early stage.